Dosidal · Switzerland

Rybelsus N, Tabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69865 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69865
atc: A10BJ06
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-11-28
term: zugelassen
valid_until: 2030-11-27
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: A10BJ06
authorisation_number: 69865
form: TAB
holder: Novo Nordisk Pharma AG
holder_partner_nr: 1000306
it_number: 07.06.2.
name: Rybelsus N, Tabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
E0reZ-MnmVFu4QArcNT4vStFUEv4Y5UpfoEHze9CeOsHl5eeHkkzfP7a-fV9Jj0DmvXuM2jZSw0bo1SHMXSe7Q
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal